{"id":16660,"date":"2026-01-11T22:26:21","date_gmt":"2026-01-11T13:26:21","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4569\/"},"modified":"2026-08-23T12:59:47","modified_gmt":"2026-08-23T03:59:47","slug":"company-4569","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4569\/","title":{"rendered":"KYORIN PHARMACEUTICAL CO LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4569","DATE":"2026-01-09","longName":"KYORIN Pharmaceutical Co., Ltd.","company_name_ja":"","fullTimeEmployees":1982,"address":"","phone":"","website":"https:\/\/www.kyorin-pharm.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":1599,"financialCurrency":"","marketCap":91865,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":126257000000,"OperatingIncome":3567000000,"operatingMargins":2.8300000000000001,"NetIncome":3448000000,"profitMargins":2.73,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":2.4199999999999999,"recommendationMean":4,"recommendationKey":"none","targetMeanPrice":1100,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:39:01.313462\", \"ticker\": \"4569\", \"ticker_full\": \"4569.T\", \"company_name\": \"KYORIN PHARMACEUTICAL CO LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"2\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 0, \"sell\": 0, \"strong_sell\": 1, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 1142.0, \"high\": 1100.0, \"low\": 1100.0, \"mean\": 1100.0, \"median\": 1100.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-11-09\", \"eps_estimate\": null, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2015-05-12\", \"eps_estimate\": 28.1, \"eps_actual\": 33.53, \"surprise_pct\": 19.32}, {\"date\": \"2015-02-01\", \"eps_estimate\": 79.0, \"eps_actual\": 81.32, \"surprise_pct\": 2.94}, {\"date\": \"2014-05-08\", \"eps_estimate\": 37.5, \"eps_actual\": 36.84, \"surprise_pct\": -1.76}, {\"date\": \"2014-02-03\", \"eps_estimate\": 65.6, \"eps_actual\": 65.26, \"surprise_pct\": -0.52}, {\"date\": \"2013-11-04\", \"eps_estimate\": 18.7, \"eps_actual\": 18.74, \"surprise_pct\": 0.21}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 32.94, \"institution_pct\": 23.97, \"major_holders\": [{\"label\": \"\", \"value\": 32.94}, {\"label\": \"\", \"value\": 23.97}, {\"label\": \"\", \"value\": 35.74}, {\"label\": \"\", \"value\": 69.0}], \"institutional_holders\": [{\"holder\": \"ADVISORS' INNER CIRCLE FUND II-KOPERNIK GLOBAL ALL-CAP FUND\", \"shares\": 2051900, \"date_reported\": \"2026-04-30\", \"pct_held\": 3.42, \"pct_change\": 8.21, \"value\": 2343269800}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 582300, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.97, \"pct_change\": 0.0, \"value\": 664986600}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 569808, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.95, \"pct_change\": 0.0, \"value\": 650720736}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 383606, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.64, \"pct_change\": 0.0, \"value\": 438078052}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Small Cap Value ETF\", \"shares\": 215700, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.36, \"pct_change\": 4.25, \"value\": 246329400}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.\", \"shares\": 190099, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.32, \"pct_change\": 0.0, \"value\": 217093058}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 188346, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.31, \"pct_change\": 44.05, \"value\": 215091132}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 156600, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.26, \"pct_change\": -0.25, \"value\": 178837200}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap \", \"shares\": 140600, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.23, \"pct_change\": 0.0, \"value\": 160565200}, {\"holder\": \"TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund\", \"shares\": 116000, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.19, \"pct_change\": 0.0, \"value\": 132472000}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":37,"get_dividend_history_year2":57,"get_dividend_history_year3":52,"get_dividend_history_year4":52,"get_dividend_history_year5":52,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:45:56.914747\", \"ticker\": \"4569\", \"ticker_full\": \"4569.T\", \"company_name\": \"KYORIN PHARMACEUTICAL CO LTD\", \"company_info\": {\"name_en\": \"KYORIN PHARMACEUTICAL CO LTD\", \"long_name\": \"KYORIN Pharmaceutical Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.kyorin-pharm.co.jp\", \"employees\": 1982, \"country\": \"Japan\", \"city\": \"Tokyo\", \"address\": \"A\", \"description\": \"KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 1144.8, \"deviation\": 1.15, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 1142.12, \"deviation\": 1.39, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 1205.88, \"deviation\": -3.97, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 1421.21, \"deviation\": -18.52, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 126257000000.0, \"revenue_fmt\": \"\u00a51263\u5104\", \"gross_profit\": 51622000000.0, \"gross_profit_fmt\": \"\u00a5516\u5104\", \"operating_income\": 3567000000.0, \"operating_income_fmt\": \"\u00a536\u5104\", \"ebit\": 4705000000.0, \"ebit_fmt\": \"\u00a547\u5104\", \"net_income\": 3448000000.0, \"net_income_fmt\": \"\u00a534\u5104\", \"eps\": 0, \"operating_margin\": 2.83, \"total_assets\": 195455000000.0, \"total_assets_fmt\": \"\u00a51955\u5104\", \"total_equity\": 142425000000.0, \"total_equity_fmt\": \"\u00a51424\u5104\", \"total_debt\": 23785000000.0, \"total_debt_fmt\": \"\u00a5238\u5104\", \"total_cash\": 11802000000.0, \"total_cash_fmt\": \"\u00a5118\u5104\", \"equity_ratio\": 72.87, \"de_ratio\": 0.17, \"current_ratio\": 4.6, \"operating_cf\": 6381000000.0, \"operating_cf_fmt\": \"\u00a564\u5104\", \"investing_cf\": -1644000000.0, \"investing_cf_fmt\": \"-\u00a516\u5104\", \"financing_cf\": -7956000000.0, \"financing_cf_fmt\": \"-\u00a580\u5104\", \"free_cf\": 2405000000.0, \"free_cf_fmt\": \"\u00a524\u5104\", \"net_margin\": 2.73, \"roe\": 2.42, \"roa\": 1.76}, {\"year\": 2025, \"revenue\": 130087000000.0, \"revenue_fmt\": \"\u00a51301\u5104\", \"gross_profit\": 59535000000.0, \"gross_profit_fmt\": \"\u00a5595\u5104\", \"operating_income\": 12568000000.0, \"operating_income_fmt\": \"\u00a5126\u5104\", \"ebit\": 12943000000.0, \"ebit_fmt\": \"\u00a5129\u5104\", \"net_income\": 9086000000.0, \"net_income_fmt\": \"\u00a591\u5104\", \"eps\": 158.17, \"operating_margin\": 9.66, \"total_assets\": 193618000000.0, \"total_assets_fmt\": \"\u00a51936\u5104\", \"total_equity\": 136284000000.0, \"total_equity_fmt\": \"\u00a51363\u5104\", \"total_debt\": 28439000000.0, \"total_debt_fmt\": \"\u00a5284\u5104\", \"total_cash\": 15021000000.0, \"total_cash_fmt\": \"\u00a5150\u5104\", \"equity_ratio\": 70.39, \"de_ratio\": 0.21, \"current_ratio\": 3.88, \"operating_cf\": 3506000000.0, \"operating_cf_fmt\": \"\u00a535\u5104\", \"investing_cf\": -6323000000.0, \"investing_cf_fmt\": \"-\u00a563\u5104\", \"financing_cf\": 3952000000.0, \"financing_cf_fmt\": \"\u00a540\u5104\", \"free_cf\": -2787000000.0, \"free_cf_fmt\": \"-\u00a528\u5104\", \"net_margin\": 6.98, \"roe\": 6.67, \"roa\": 4.69}, {\"year\": 2024, \"revenue\": 119532000000.0, \"revenue_fmt\": \"\u00a51195\u5104\", \"gross_profit\": 51628000000.0, \"gross_profit_fmt\": \"\u00a5516\u5104\", \"operating_income\": 6234000000.0, \"operating_income_fmt\": \"\u00a562\u5104\", \"ebit\": 7305000000.0, \"ebit_fmt\": \"\u00a573\u5104\", \"net_income\": 5475000000.0, \"net_income_fmt\": \"\u00a555\u5104\", \"eps\": 92.74, \"operating_margin\": 5.22, \"total_assets\": 177627000000.0, \"total_assets_fmt\": \"\u00a51776\u5104\", \"total_equity\": 130733000000.0, \"total_equity_fmt\": \"\u00a51307\u5104\", \"total_debt\": 20946000000.0, \"total_debt_fmt\": \"\u00a5209\u5104\", \"total_cash\": 13886000000.0, \"total_cash_fmt\": \"\u00a5139\u5104\", \"equity_ratio\": 73.6, \"de_ratio\": 0.16, \"current_ratio\": 2.62, \"operating_cf\": 1549000000.0, \"operating_cf_fmt\": \"\u00a515\u5104\", \"investing_cf\": -3187000000.0, \"investing_cf_fmt\": \"-\u00a532\u5104\", \"financing_cf\": -3347000000.0, \"financing_cf_fmt\": \"-\u00a533\u5104\", \"free_cf\": -4697000000.0, \"free_cf_fmt\": \"-\u00a547\u5104\", \"net_margin\": 4.58, \"roe\": 4.19, \"roa\": 3.08}, {\"year\": 2023, \"revenue\": 113270000000.0, \"revenue_fmt\": \"\u00a51133\u5104\", \"gross_profit\": 50167000000.0, \"gross_profit_fmt\": \"\u00a5502\u5104\", \"operating_income\": 5124000000.0, \"operating_income_fmt\": \"\u00a551\u5104\", \"ebit\": 6972000000.0, \"ebit_fmt\": \"\u00a570\u5104\", \"net_income\": 4723000000.0, \"net_income_fmt\": \"\u00a547\u5104\", \"eps\": 82.44, \"operating_margin\": 4.52, \"total_assets\": 176045000000.0, \"total_assets_fmt\": \"\u00a51760\u5104\", \"total_equity\": 125460000000.0, \"total_equity_fmt\": \"\u00a51255\u5104\", \"total_debt\": 21277000000.0, \"total_debt_fmt\": \"\u00a5213\u5104\", \"total_cash\": 19394000000.0, \"total_cash_fmt\": \"\u00a5194\u5104\", \"equity_ratio\": 71.27, \"de_ratio\": 0.17, \"current_ratio\": 3.4, \"operating_cf\": 2008000000.0, \"operating_cf_fmt\": \"\u00a520\u5104\", \"investing_cf\": -6275000000.0, \"investing_cf_fmt\": \"-\u00a563\u5104\", \"financing_cf\": -3363000000.0, \"financing_cf_fmt\": \"-\u00a534\u5104\", \"free_cf\": -7397000000.0, \"free_cf_fmt\": \"-\u00a574\u5104\", \"net_margin\": 4.17, \"roe\": 3.76, \"roa\": 2.68}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 68.62, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 52.0}, {\"year\": 2023, \"amount\": 52.0}, {\"year\": 2024, \"amount\": 52.0}, {\"year\": 2025, \"amount\": 57.0}, {\"year\": 2026, \"amount\": 37.0}], \"latest\": 37.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-16660","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KYORIN PHARMACEUTICAL CO LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4569\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4569\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4569\/\",\"name\":\"KYORIN PHARMACEUTICAL CO LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-01-11T13:26:21+00:00\",\"dateModified\":\"2026-08-23T03:59:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4569\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4569\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4569\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KYORIN PHARMACEUTICAL CO LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KYORIN PHARMACEUTICAL CO LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4569\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4569\/","url":"https:\/\/japanir.jp\/en\/company\/company-4569\/","name":"KYORIN PHARMACEUTICAL CO LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-01-11T13:26:21+00:00","dateModified":"2026-08-23T03:59:47+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4569\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4569\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4569\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"KYORIN PHARMACEUTICAL CO LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/16660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=16660"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=16660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}